Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant987 active trials8 approved drugs63 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,216 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05566093 | EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors | unknown | N/A | 20 | Guangxi Medical UniversityOTHER | 1 | Oct 4, 2022 | clinicaltrials |
| NCT05566743 | A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas | unknown | Phase 2 | 40 | Menoufia UniversityOTHER | 1 | Oct 4, 2022 | clinicaltrials |
| NCT05554744 |
| EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors |
| unknown |
| N/A |
| 20 |
| Guangxi Medical UniversityOTHER |
| 1 |
| Sep 27, 2022 |
| clinicaltrials |
| NCT03957135 | Laparoscopic Versus Open Distal Pancreatectomy for Pancreatic Cancer: a Multicenter Randomized Controlled Trial | unknown | N/A | 244 | Seoul National University HospitalOTHER | 1 | Sep 21, 2022 | clinicaltrials |
| NCT04801095 | A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 100 | Wellmarker BioINDUSTRY | 2 | Sep 16, 2022 | clinicaltrials |
| NCT03487016 | First-line Therapy in Metastatic PDAC(FOOTPATH) | unknown | Phase 2 | 270 | Ludwig-Maximilians - University of MunichOTHER | 1 | Sep 8, 2022 | clinicaltrials |
| NCT04398446 | Effect of Hemp-CBD on Patients With CIPN(Coala-T-CBD) | unknown | Phase 2 | 56 | Main Line HealthOTHER | 1 | Sep 1, 2022 | clinicaltrials |
| NCT03069664 | Palliative Pancreatic Duct Stenting in Patients With Inoperable Pancreatic Cancer | unknown | N/A | 40 | Helsinki University Central HospitalOTHER | 1 | Aug 16, 2022 | clinicaltrials |
| NCT05500027 | sCD8, as a Novel Biomarker for Pancreatic Cancer | unknown | — | 2,000 | Peking Union Medical College HospitalOTHER | 1 | Aug 12, 2022 | clinicaltrials |
| NCT05181605 | Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors | unknown | Phase 2 / Phase 3 | 116 | Instituto de investigación e innovación biomédica de CádizOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT05493878 | ITGA2b and SELP Expression in Cancer Pancreas and Biliary Tract Cancer | unknown | — | 128 | Assiut UniversityOTHER | 0 | Aug 9, 2022 | clinicaltrials |
| NCT05489419 | Evaluation of Prehabilitation as a Strategy to Minimize Surgical Risk in Pancreatic Surgery: Efficacy and Determining Factors. | unknown | N/A | 56 | Hospital Clinic of BarcelonaOTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT04931381 | Organoid-Guided Chemotherapy for Advanced Pancreatic Cancer | unknown | Phase 3 | 100 | Changhai HospitalOTHER | 1 | Aug 2, 2022 | clinicaltrials |
| NCT04931394 | Organoid-Guided Adjuvant Chemotherapy for Pancreatic Cancer | unknown | Phase 3 | 200 | Changhai HospitalOTHER | 1 | Aug 2, 2022 | clinicaltrials |
| NCT05470738 | PAncreas Borderline and Locally Advanced Snapshot Study(PALASS) | unknown | — | 230 | University Hospital, Clermont-FerrandOTHER | 1 | Jul 22, 2022 | clinicaltrials |
| NCT04110769 | Development of Biomarker for the Evaluation of Response After Neoadjuvant Therapy in Patients With Pancreatic Cancer | unknown | N/A | 10 | Asan Medical CenterOTHER | 1 | Jul 20, 2022 | clinicaltrials |
| NCT04136522 | Usefulness of the Artery First Approach in Pancreatic Cancer Surgery | unknown | N/A | 268 | Asan Medical CenterOTHER | 1 | Jul 20, 2022 | clinicaltrials |
| NCT05463328 | Open Versus Laparoscopic Assisted Pancreaticoduodenectomy | unknown | N/A | 40 | Assiut UniversityOTHER | 0 | Jul 19, 2022 | clinicaltrials |
| NCT04892329 | A Multi-center Study on the Efficacy and Safety of AI-assisted Navigation System for Biliopancreatic EUS | unknown | N/A | 285 | Renmin Hospital of Wuhan UniversityOTHER | 1 | Jul 5, 2022 | clinicaltrials |
| NCT05438797 | The Safety and Efficacy of Specific TIL-TCM Cells for Advanced Relapse-refractory or Metastatic Pancreatic Cancer | unknown | Early Phase 1 | 3 | Sizhen WangOTHER | 1 | Jun 30, 2022 | clinicaltrials |
| NCT05436704 | Is One Pass Enough for the Diagnosis of the Pancreatic Masses During EUS-FNB?(ONE PASS) | unknown | — | 79 | Istituto Clinico Humanitas Mater DominiOTHER | 1 | Jun 29, 2022 | clinicaltrials |
| NCT03792932 | Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic Cancer | unknown | N/A | 306 | Fudan UniversityOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT05369312 | Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients | unknown | Phase 1 | 230 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jun 21, 2022 | clinicaltrials |
| NCT04418739 | Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes | unknown | Phase 2 | 122 | Universiti Kebangsaan Malaysia Medical CentreOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT04258072 | Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma. | unknown | Phase 1 | 24 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT05400681 | Liquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic Cancer(LIPAC) | unknown | — | 200 | Sonke DetlefsenOTHER | 1 | Jun 8, 2022 | clinicaltrials |
| NCT05399394 | Induction FOLFIRINOX Followed by Chemoradiation in Locally Advanced Pancreatic Cancer(FOLRT) | unknown | Phase 2 | 50 | Campus Bio-Medico UniversityOTHER | 0 | Jun 1, 2022 | clinicaltrials |
| NCT02839343 | Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer | unknown | Phase 2 | 126 | Alliance for Clinical Trials in OncologyOTHER | 2 | May 24, 2022 | clinicaltrials |
| NCT03770559 | The Therapeutic Evaluation(Both Short-term and Long-term Outcome) of Minimal Invasive Radical Antegrade Modular Pancreatosplenectomy for Left-sided Pancreatic Cancer Patients(MIRROR) | unknown | N/A | 125 | Peking Union Medical College HospitalOTHER | 1 | May 20, 2022 | clinicaltrials |
| NCT03741517 | Biomarker Study of Pancreatic Neuroendocrine Tumours | unknown | — | 40 | Uppsala UniversityOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT04235556 | Integrated Care Pathway in Oncology (PASSION)(PASSION) | unknown | — | 1,800 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 13, 2022 | clinicaltrials |
| NCT05329597 | Study on Umorestat Hydrogen Sulfate Capsule in Patients With Locally Advanced/Metastatic Pancreatic Cancer | unknown | — | 88 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Apr 15, 2022 | clinicaltrials |
| NCT05327582 | An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC | unknown | Phase 1 / Phase 2 | 65 | Chinese PLA General HospitalOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT03958019 | Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary Cancer(RESTORE II) | unknown | N/A | 120 | University of Dublin, Trinity CollegeOTHER | 1 | Apr 13, 2022 | clinicaltrials |
| NCT05313854 | Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image Data | unknown | — | 1,000 | RenJi HospitalOTHER | 1 | Apr 6, 2022 | clinicaltrials |
| NCT05178628 | The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer(imPaCT-PRO) | unknown | Phase 3 | 450 | Michalis KaramouzisOTHER | 1 | Mar 29, 2022 | clinicaltrials |
| NCT05298020 | Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer | unknown | Phase 2 | 20 | The Affiliated Hospital of Xuzhou Medical UniversityOTHER | 1 | Mar 28, 2022 | clinicaltrials |
| NCT05289895 | Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Techniques | unknown | — | 220 | The Affiliated Hospital of Qingdao UniversityOTHER | 0 | Mar 22, 2022 | clinicaltrials |
| NCT05253313 | Magnetic Resonance Imaging for Better Selection of Pancreatic Cancer Patients for Surgery: A Randomized Clinical Trial(MAGIPAC) | unknown | N/A | 200 | University of AarhusOTHER | 0 | Mar 16, 2022 | clinicaltrials |
| NCT05275062 | Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma | unknown | Early Phase 1 | 6 | Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY | 1 | Mar 11, 2022 | clinicaltrials |
| NCT05275985 | 68Ga-FAPI PET/CT in Pancreatic Ductal Carcinoma | unknown | N/A | 80 | Peking Union Medical College HospitalOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT04835402 | Electroporation Potentiated Immunotherapy in Cancer(EPIC-1) | unknown | Phase 2 | 8 | Ole Thorlacius-Ussing, MD, DMSc, Professor of SurgeryOTHER | 1 | Mar 9, 2022 | clinicaltrials |
| NCT05162118 | Clinical Study of VG161 in Combination With Nivolumab in Subjects With Advanced Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 51 | Zhejiang UniversityOTHER | 1 | Mar 9, 2022 | clinicaltrials |
| NCT05270564 | Post-operative Drainage After Pancreaticoduodenectomy(Drain 1) | unknown | N/A | 300 | Linkoeping UniversityOTHER_GOV | 1 | Mar 8, 2022 | clinicaltrials |
| NCT05259384 | Robotic Versus Laparoscopic Surgery for Patients With Pancreatic Cystic Neoplasms | unknown | N/A | 120 | Peking Union Medical College HospitalOTHER | 1 | Feb 28, 2022 | clinicaltrials |
| NCT04812808 | Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic Adenocarcinoma(BAZE) | unknown | N/A | 10 | Hôpital FribourgeoisOTHER | 1 | Feb 25, 2022 | clinicaltrials |
| NCT05257122 | A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer | unknown | Phase 2 | 32 | Fudan UniversityOTHER | 1 | Feb 25, 2022 | clinicaltrials |
| NCT03221400 | PEN-866 in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 340 | Tarveda TherapeuticsINDUSTRY | 1 | Feb 17, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Oct 4, 2022source: clinicaltrials